Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Intangibles (2016 - 2025)

Angiodynamics (ANGO) has disclosed Intangibles for 15 consecutive years, with $68.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Intangibles changed N/A year-over-year to $68.4 million, compared with a TTM value of $68.4 million through Aug 2025, changed N/A, and an annual FY2025 reading of $69.1 million, down 10.68% over the prior year.
  • Intangibles was $68.4 million for Q3 2025 at Angiodynamics, down from $69.1 million in the prior quarter.
  • Across five years, Intangibles topped out at $169.0 million in Q2 2021 and bottomed at $68.4 million in Q3 2025.
  • Average Intangibles over 5 years is $123.4 million, with a median of $134.0 million recorded in 2023.
  • The sharpest move saw Intangibles decreased 9.82% in 2022, then plummeted 39.13% in 2024.
  • Year by year, Intangibles stood at $165.0 million in 2021, then decreased by 13.97% to $141.9 million in 2022, then fell by 24.85% to $106.7 million in 2023, then fell by 27.46% to $77.4 million in 2024, then decreased by 11.63% to $68.4 million in 2025.
  • Business Quant data shows Intangibles for ANGO at $68.4 million in Q3 2025, $69.1 million in Q2 2025, and $77.4 million in Q2 2024.